Effects of malnutrition and chronic reserpine treatment on pancreatic exocrine function

Dee Hazlett, Murray Korc, Patsy M. Brannon

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The chronically reserpine-treated rat, an experimental model for cystic fibrosis, exhibits generalized exocrinopathy, impaired pancreatic secretion, and decreased pancreatic amylase. Although chronic reserpine treatment induces malnutrition by decreasing food consumption and growth, the effects of this malnutrition per se on the exocrine pancreas have not been considered. In this study, the effects of chronic reserpine treatment and malnutrition on the exocrine pancreas were determined using pair-fed controls. Male, Sprague-Dawley rats were treated daily subcutaneously for 5 to 7 days with: 1) no injection (control), 2) 1.0 ml/kg vehicle or sham (control-sham, pair fed-sham), or 3) 0.5 mg/kg reserpine (chronically reserpine-treated). Both chronic reserpine-treatment and pair-feeding significantly decreased food consumption (40%), body weight (51 and 59%), total pancreatic amylase (49 and 56%) and specific amylase activity (62 and 61%), pancreatic protein (65 and 75%), and pancreatic weights (62 and 65%) compared to controls. These decreases, however, were comparable between the chronically reserpine-treated and pair fed-sham rats. In contrast, the secretory response to the biologically active cholecystokinin analog cholecystokinin octapeptide was significantly attenuated in isolated pancreatic acini prepared from reserpine-treated rats compared to that from either control or pair-fed sham rats. Malnutrition decreased pancreatic amylase activity and protein comparably to reserpine treatment, but only partially attenuated the secretory response to cholecystokinin octapeptide. Based on the results of this study, pair-fed controls should be used to distinguish between the effects of reserpine alone and the induced malnutrition on pancreatic exocrine function in studies of this experimental model of cystic fibrosis.

Original languageEnglish (US)
Pages (from-to)1236-1239
Number of pages4
JournalPediatric Research
Volume20
Issue number12
StatePublished - 1986
Externally publishedYes

Fingerprint

Reserpine
Malnutrition
Amylases
Therapeutics
Sincalide
Exocrine Pancreas
Cystic Fibrosis
Theoretical Models
Food
Cholecystokinin
Sprague Dawley Rats
Proteins
Body Weight
Weights and Measures
Injections

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Hazlett, D., Korc, M., & Brannon, P. M. (1986). Effects of malnutrition and chronic reserpine treatment on pancreatic exocrine function. Pediatric Research, 20(12), 1236-1239.

Effects of malnutrition and chronic reserpine treatment on pancreatic exocrine function. / Hazlett, Dee; Korc, Murray; Brannon, Patsy M.

In: Pediatric Research, Vol. 20, No. 12, 1986, p. 1236-1239.

Research output: Contribution to journalArticle

Hazlett, D, Korc, M & Brannon, PM 1986, 'Effects of malnutrition and chronic reserpine treatment on pancreatic exocrine function', Pediatric Research, vol. 20, no. 12, pp. 1236-1239.
Hazlett, Dee ; Korc, Murray ; Brannon, Patsy M. / Effects of malnutrition and chronic reserpine treatment on pancreatic exocrine function. In: Pediatric Research. 1986 ; Vol. 20, No. 12. pp. 1236-1239.
@article{0b2f37a750e548058dceb5515a8306ad,
title = "Effects of malnutrition and chronic reserpine treatment on pancreatic exocrine function",
abstract = "The chronically reserpine-treated rat, an experimental model for cystic fibrosis, exhibits generalized exocrinopathy, impaired pancreatic secretion, and decreased pancreatic amylase. Although chronic reserpine treatment induces malnutrition by decreasing food consumption and growth, the effects of this malnutrition per se on the exocrine pancreas have not been considered. In this study, the effects of chronic reserpine treatment and malnutrition on the exocrine pancreas were determined using pair-fed controls. Male, Sprague-Dawley rats were treated daily subcutaneously for 5 to 7 days with: 1) no injection (control), 2) 1.0 ml/kg vehicle or sham (control-sham, pair fed-sham), or 3) 0.5 mg/kg reserpine (chronically reserpine-treated). Both chronic reserpine-treatment and pair-feeding significantly decreased food consumption (40{\%}), body weight (51 and 59{\%}), total pancreatic amylase (49 and 56{\%}) and specific amylase activity (62 and 61{\%}), pancreatic protein (65 and 75{\%}), and pancreatic weights (62 and 65{\%}) compared to controls. These decreases, however, were comparable between the chronically reserpine-treated and pair fed-sham rats. In contrast, the secretory response to the biologically active cholecystokinin analog cholecystokinin octapeptide was significantly attenuated in isolated pancreatic acini prepared from reserpine-treated rats compared to that from either control or pair-fed sham rats. Malnutrition decreased pancreatic amylase activity and protein comparably to reserpine treatment, but only partially attenuated the secretory response to cholecystokinin octapeptide. Based on the results of this study, pair-fed controls should be used to distinguish between the effects of reserpine alone and the induced malnutrition on pancreatic exocrine function in studies of this experimental model of cystic fibrosis.",
author = "Dee Hazlett and Murray Korc and Brannon, {Patsy M.}",
year = "1986",
language = "English (US)",
volume = "20",
pages = "1236--1239",
journal = "Pediatric Research",
issn = "0031-3998",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Effects of malnutrition and chronic reserpine treatment on pancreatic exocrine function

AU - Hazlett, Dee

AU - Korc, Murray

AU - Brannon, Patsy M.

PY - 1986

Y1 - 1986

N2 - The chronically reserpine-treated rat, an experimental model for cystic fibrosis, exhibits generalized exocrinopathy, impaired pancreatic secretion, and decreased pancreatic amylase. Although chronic reserpine treatment induces malnutrition by decreasing food consumption and growth, the effects of this malnutrition per se on the exocrine pancreas have not been considered. In this study, the effects of chronic reserpine treatment and malnutrition on the exocrine pancreas were determined using pair-fed controls. Male, Sprague-Dawley rats were treated daily subcutaneously for 5 to 7 days with: 1) no injection (control), 2) 1.0 ml/kg vehicle or sham (control-sham, pair fed-sham), or 3) 0.5 mg/kg reserpine (chronically reserpine-treated). Both chronic reserpine-treatment and pair-feeding significantly decreased food consumption (40%), body weight (51 and 59%), total pancreatic amylase (49 and 56%) and specific amylase activity (62 and 61%), pancreatic protein (65 and 75%), and pancreatic weights (62 and 65%) compared to controls. These decreases, however, were comparable between the chronically reserpine-treated and pair fed-sham rats. In contrast, the secretory response to the biologically active cholecystokinin analog cholecystokinin octapeptide was significantly attenuated in isolated pancreatic acini prepared from reserpine-treated rats compared to that from either control or pair-fed sham rats. Malnutrition decreased pancreatic amylase activity and protein comparably to reserpine treatment, but only partially attenuated the secretory response to cholecystokinin octapeptide. Based on the results of this study, pair-fed controls should be used to distinguish between the effects of reserpine alone and the induced malnutrition on pancreatic exocrine function in studies of this experimental model of cystic fibrosis.

AB - The chronically reserpine-treated rat, an experimental model for cystic fibrosis, exhibits generalized exocrinopathy, impaired pancreatic secretion, and decreased pancreatic amylase. Although chronic reserpine treatment induces malnutrition by decreasing food consumption and growth, the effects of this malnutrition per se on the exocrine pancreas have not been considered. In this study, the effects of chronic reserpine treatment and malnutrition on the exocrine pancreas were determined using pair-fed controls. Male, Sprague-Dawley rats were treated daily subcutaneously for 5 to 7 days with: 1) no injection (control), 2) 1.0 ml/kg vehicle or sham (control-sham, pair fed-sham), or 3) 0.5 mg/kg reserpine (chronically reserpine-treated). Both chronic reserpine-treatment and pair-feeding significantly decreased food consumption (40%), body weight (51 and 59%), total pancreatic amylase (49 and 56%) and specific amylase activity (62 and 61%), pancreatic protein (65 and 75%), and pancreatic weights (62 and 65%) compared to controls. These decreases, however, were comparable between the chronically reserpine-treated and pair fed-sham rats. In contrast, the secretory response to the biologically active cholecystokinin analog cholecystokinin octapeptide was significantly attenuated in isolated pancreatic acini prepared from reserpine-treated rats compared to that from either control or pair-fed sham rats. Malnutrition decreased pancreatic amylase activity and protein comparably to reserpine treatment, but only partially attenuated the secretory response to cholecystokinin octapeptide. Based on the results of this study, pair-fed controls should be used to distinguish between the effects of reserpine alone and the induced malnutrition on pancreatic exocrine function in studies of this experimental model of cystic fibrosis.

UR - http://www.scopus.com/inward/record.url?scp=0023030728&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023030728&partnerID=8YFLogxK

M3 - Article

VL - 20

SP - 1236

EP - 1239

JO - Pediatric Research

JF - Pediatric Research

SN - 0031-3998

IS - 12

ER -